$233.85
$0.00 (0.00%)
End-of-day quote: 04/26/2024
NasdaqGS:UTHR

United Therapeutics Annual Report

Year Year 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Rev. Revenue
$2.33B $1.94B $1.69B $1.48B $1.45B $1.63B $1.73B $1.60B $1.47B $1.29B $1.12B $916.08M $743.18M $592.90M $358.88M $281.50M $210.94M $159.63M $115.92M $73.59M
GM % Gross Margin %
88.94% 92.17% 92.73% 92.71% 91.88% 87.79% 93.87% 95.45% 95.29% 90.23% 88.26% 86.98% 88.04% 88.59% 88.61% 89.32% 89.45% 89.33% 89.38% 88.79%
OM Operating Margin
50.96% 51.08% 40.75% 39.84% -12.26% 49.30% 59.26% 66.25% 47.69% 41.82% 26.19% 46.77% 43.43% 28.89% 8.43% 24.14% 2.99% 19.42% 37.00% 17.95%
EPS Earnings Per Share
$0.00 $19.81 $16.71 $15.26 $14.46 $12.94 $15.36 $16.51 $16.00 $12.72 $6.48 $3.28 $5.78 $3.67 $1.85 $0.35 $1.22 $0.44 $1.31 $0.95 $0.33
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0 0 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0 0
Sha. Shares
47.04m 46.03m 45.11m 44.51m 43.88m 43.59m 43.24m 42.97m 45.76m 47.11m 50.39m 50.17m 53.61m 57.56m 54.22m 52.86m 44.5m 42.95m 46.64m 44.86m
OCF Operating Cash Flow
$978.00M $802.50M $598.20M $755.70M $-206.60M $778.40M $474.20M $643.60M $382.80M $355.30M $425.27M $323.63M $250.20M $211.53M $99.72M $-40.43M $48.94M $49.26M $43.17M $20.78M
FCF Free Cash Flow
$889.50M $663.70M $477.40M $696.40M $-290.30M $594.00M $387.90M $605.60M $332.97M $307.82M $393.36M $211.72M $214.22M $192.89M $4.32M $-164.85M $10.28M $33.63M $37.05M $15.56M
FCFS Free Cash Flow Per Share
$15.97 $14.59 $10.63 $15.76 $-6.63 $13.66 $8.82 $13.83 $14.85 $6.39 $7.86 $4.06 $3.75 $3.44 $0.08 $-3.60 $0.24 $0.73 $0.81 $0.36